1. Market Overview
The oncology sector remains the most dominant area in healthcare, with over 50% of ongoing clinical trials focused on cancer treatment. In 2023, the global oncology market was valued at $222.36 billion and is projected to reach $521.6 billion by 2033, growing at a CAGR of 8.9% from 2024 onward.
With personalized medicine, AI-driven drug discovery, and innovative treatment modalities shaping the landscape, big pharma, biotech startups, and investors are strategically positioning themselves to capitalize on these advancements.
2. Key Trends Shaping Oncology in 2025
Precision Medicine & Targeted Therapies
- Advances in genomic profiling and biomarker-driven treatments are enabling personalized oncology care.
- Liquid biopsy technologies and companion diagnostics are improving early detection and treatment selection.
Antibody-Drug Conjugates (ADCs) Take Center Stage
- ADCs, which deliver chemotherapy directly to cancer cells, are becoming a key alternative to traditional chemotherapy.
- Companies like Daiichi Sankyo, AstraZeneca, and Pfizer are aggressively expanding their ADC portfolios.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
